SciELO - Scientific Electronic Library Online

 
vol.90 número2Evaluación de la estrategia farmacoinvasiva versus angioplastia coronaria transluminal percutánea primaria en pacientes con infarto agudo de miocardio con elevación del segmento ST en el Instituto Nacional de Cardiología (PHASE-MX)Formulación para reducir las palpitaciones cardiacas, una receta médica de mediados del siglo xviii en el Nuevo Reino de Granada índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Archivos de cardiología de México

versión On-line ISSN 1665-1731versión impresa ISSN 1405-9940

Resumen

ABUNDES-VELASCO, Arturo et al. Design and manufacture of a coronary stent INC-1 and initial tests in experimental animal model. Arch. Cardiol. Méx. [online]. 2020, vol.90, n.2, pp.142-147.  Epub 23-Oct-2020. ISSN 1665-1731.  https://doi.org/10.24875/acme.m20000108.

In this paper, we describe our coronary stent (INC-1) design and development, the way that we found the specific characteristics needed for our device including biophysics aspects, design, finite element testing, manufacturing, and mechanic trials, we submitted and animal models experiences. The stent platform was cobalt-chromium L605 (Co-Cr), with struts thickness of 80 μm, balloon expandable. We placed the coronary stent INC-1 on a rabbit and dog models so we can evaluate efficacy and security of the device in relationship to its biomechanical properties including navigation capacity, traceability, symmetric expansion, and safety, as well as endothelial attachment, thrombogenicity, and lack of involvement of secondary branches in these models. We succeeded in efficacy and safety of the device after fluoroscopy-guided implant proving excellent capacity of release system, traceability, fluoroscopic visualization, symmetric expansion, and complete endothelial attach. Furthermore, we obtained a good post-implant balloon withdrawal, functional integrity, and no vascular complications. We observed adequate clinical evolution 3 weeks after the stent implantation.

Palabras llave : Stent; Novel bare metal stent; Myocardial infarction; Percutaneous coronary intervention.

        · resumen en Español     · texto en Inglés